Organon & Co | Dochód Netto



Net Income Zmiana Data
Adcock Ingram Holdings ZAR 389.71M 19.87M 2024-12
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Celltrion KRW 108.67B 127.98B 2025-03
Cspc Pharmaceutical CNY 1.48B 927.97M 2025-03
Dianthus Therapeutics USD -31629000 3.19M 2025-06
Divis Laboratories Ltd 5.45B 1.17B 2025-06
Gilead Sciences USD 1.96B 645M 2025-06
Glaxosmithkline GBP 1.44B 1.03B 2025-06
Kangmei Pharma CNY 8.4M 110.17K 2025-06
Knight Therapeutics CAD 85K 2.03M 2024-09
Laboratorios Farma EUR 21.64M 70.9M 2025-06
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 304K 15.32M 2024-12
Merck USD 4.43B 652M 2025-06
Neuren Pharmaceuticals AUD 134.03M 126.01M 2024-12
Novartis USD 4.04B 1.22B 2025-06
Organigram Holdings CAD -6290000 16.67M 2025-06
Organon & Co USD 145M 58M 2025-06
Pharma Mar EUR 23.37M 27.32M 2025-06
Qiagen NV USD 96.25M 5.49M 2025-06
Sartorius EUR 32.5M 15.9M 2025-06
Sino Biopharmaceutical CNY 482.67M 2.53B 2024-12
Tilray USD -85342000 46.18M 2024-11


Organon & Co Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Sep 2025.